HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Xu Deng Selected Research

cheliensisin A

2/2014Hydrogen peroxide/ATR-Chk2 activation mediates p53 protein stabilization and anti-cancer activity of cheliensisin A in human cancer cells.
9/2013Cheliensisin A inhibits EGF-induced cell transformation with stabilization of p53 protein via a hydrogen peroxide/Chk1-dependent axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Xu Deng Research Topics

Disease

4Neoplasms (Cancer)
01/2015 - 09/2011
3Coronary Artery Disease (Coronary Atherosclerosis)
04/2015 - 08/2014
1Infection
07/2015
1Stomach Neoplasms (Stomach Cancer)
01/2015
1Neoplasm Metastasis (Metastasis)
01/2015
1Inflammation
11/2014
1Leukemia
09/2013

Drug/Important Bio-Agent (IBA)

2Biological Markers (Surrogate Marker)IBA
04/2015 - 01/2015
2cheliensisin AIBA
02/2014 - 09/2013
1VaccinesIBA
07/2015
1MicroRNAs (MicroRNA)IBA
04/2015
1Matrix Metalloproteinase 15IBA
01/2015
1Peptide Hydrolases (Proteases)IBA
01/2015
1Matrix MetalloproteinasesIBA
01/2015
1eriocalyxin BIBA
11/2014
1NF-kappa B (NF-kB)IBA
11/2014
1Cysteine (L-Cysteine)FDA Link
11/2014
1kaureneIBA
11/2014
1AdiponectinIBA
08/2014
1Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
08/2014
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
02/2014
1Cisplatin (Platino)FDA LinkGeneric
09/2011